Gabriel Scientific in €2.3m Middle East deal

The Irish company behind an infection-resistant range of bedding products is valuing a distribution agreement in the Middle East at US$3 million (€2.3 million).

27th July, 2013
Ayman Saleh, group chief executive, Julphur Pharmaceuticals; Sheikh Saqer Humaid Al Qasimi, Douglas Collins, Gabriel Scientific; and Rajiv Nakani, director Planet Pharmacy.

**Done Deal:** €2.3 million

**The clincher:** "This third deal will see us build our business in the growing Arab health sector. We have invested resources to establish our credentials as key innovators and to capture market share and growth." - *David Woolfson, founder*


Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago